USPTO serial 79446376
Reviewed by CopyMark Law Group
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Deadline: 31 Oct 2026
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The examiner has identified that you need to address a likelihood of confusion refusal, provide your email address, and appoint a U.S.-licensed attorney.
Section 2(d): Likelihood of Confusion
Cited marks: 79287768
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicinal preparations for oral, nasal, and topical applications in the form of sprays for the prevention and treatment of pathogenic biofilm derived infections; medicinal preparations for the mouth and as sprays; decongestant nasal sprays | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 27, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 31, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 31, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 9, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 8, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 1, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 23, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 23, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 23, 2026 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Mar 19, 2026 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |